Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Efsevia Vakiani, Ronak H. Shah, Michael F. Berger, Alvin P. Makohon-Moore, Johannes G. Reiter, Irina Ostrovnaya, Marc A. Attiyeh, Andrea Cercek, Jinru Shia, Christine A. Iacobuzio-Donahue, David B. Solit, Martin R. Weiser
Published Apr 18, 2017 · Vol. 8, No. 26 · pp. 42487-42494
James Meehan, Carol Ward, Arran Turnbull, Jimi Bukowski-Wills, Andrew J. Finch, Edward J. Jarman, Chrysi Xintaropoulou, Carlos Martinez-Perez, Mark Gray, Matthew Pearson, Peter Mullen, Claudiu T. Supuran, Fabrizio Carta, David J. Harrison, Ian H. Kunkler, Simon P. Langdon
Published Apr 17, 2017 · Vol. 8, No. 26 · pp. 42857-42875
Miriam S. Butler, Mani Roshan-Moniri, Michael Hsing, Desmond Lau, Ari Kim, Paul Yen, Marta Mroczek, Mannan Nouri, Scott Lien, Peter Axerio-Cilies, Kush Dalal, Clement Yau, Fariba Ghaidi, Yubin Guo, Takeshi Yamazaki, Sam Lawn, Martin E. Gleave, Cheryl Y. Gregory-Evans, Lawrence P. McIntosh, Michael E. Cox, Paul S. Rennie, Artem Cherkasov
Published Apr 15, 2017 · Vol. 8, No. 26 · pp. 42438-42454